Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/3016% below fair value

$1.40−0.10 (-6.67%)

Close on Nov 12, 2026Market cap $11.73MP/E –Yield –

Femasys enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Femasys's enterprise value was $3.09M on Nov 11, 2026, against $43.21M a year earlier. Over the last 5 years it ranged from -$5.77M to $43.21M, with a median of $8.24M.

Enterprise Value at the end of each year

Period	Period end	Value	Change
2026	Nov 11, 2026	$3.09M	-86.4%
2025	Dec 31, 2025	$22.69M	+34.7%
2024	Dec 31, 2024	$16.84M	+144.1%
2023	Dec 29, 2023	$6.90M	–
2022	Dec 30, 2022	-$5.37M	-128.7%
2021	Dec 31, 2021	$18.74M	–

Where these numbers come from

Parsed from the XBRL in Femasys's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-20 reverse split on Jun 8, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is FEMY.

Compare: FEMY vs IVF · FEMY vs OSRH · FEMY vs SINT · FEMY vs INBS · FEMY vs ICCM

Revenue growth21.9% · median 36.5%

Gross margin60.9% · median 50.9%

Operating margin-763.9% · median -287.8%

Net margin-511.8% · median -269.3%

Company	Revenue	Growth
IVF	$7.53M	–
INBS	$4.50M	+36.5%
SINT	$3.31M	+160.8%
FEMY	$2.30M	+21.9%
OSRH	$1.81M	-50.2%
ICCM	–	–

Company

Next earnings (est.): Nov 13, 2026, after close
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 51
Held by institutions: 24.7%
Auditor: KPMG LLP
SEC CIK: 1339005

Advertisement
300 × 250

See a number that looks wrong?